

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.11185078 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98737114 |
| 3 | negative regulation of cell killing (GO:0031342) | 3.96482560 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.96482560 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91449822 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.76898448 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70200648 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.70200648 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70200648 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70200648 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70200648 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.70200648 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.68195723 |
| 14 | protein localization to endosome (GO:0036010) | 3.64002924 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63170558 |
| 16 | response to peptidoglycan (GO:0032494) | 3.37370399 |
| 17 | detection of other organism (GO:0098543) | 3.33030402 |
| 18 | pinocytosis (GO:0006907) | 3.16665369 |
| 19 | detection of bacterium (GO:0016045) | 3.16580068 |
| 20 | leukocyte aggregation (GO:0070486) | 3.10425687 |
| 21 | response to laminar fluid shear stress (GO:0034616) | 3.08183927 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 3.06425737 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 3.06425737 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 2.97767675 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 2.97315847 |
| 26 | response to muramyl dipeptide (GO:0032495) | 2.97201558 |
| 27 | detection of external biotic stimulus (GO:0098581) | 2.94062706 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93334144 |
| 29 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.90622512 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 2.85575095 |
| 31 | embryonic process involved in female pregnancy (GO:0060136) | 2.81882107 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 2.78530568 |
| 33 | hypotonic response (GO:0006971) | 2.77330501 |
| 34 | mannose metabolic process (GO:0006013) | 2.77315951 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77220427 |
| 36 | germinal center formation (GO:0002467) | 2.75237698 |
| 37 | barbed-end actin filament capping (GO:0051016) | 2.71465553 |
| 38 | cellular extravasation (GO:0045123) | 2.70956812 |
| 39 | stress fiber assembly (GO:0043149) | 2.69916174 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67056130 |
| 41 | modulation by symbiont of host cellular process (GO:0044068) | 2.65968639 |
| 42 | response to interleukin-15 (GO:0070672) | 2.65871791 |
| 43 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64874686 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 2.64683398 |
| 45 | cellular response to type I interferon (GO:0071357) | 2.63513391 |
| 46 | type I interferon signaling pathway (GO:0060337) | 2.63513391 |
| 47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62530044 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 2.61863884 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61416455 |
| 50 | response to type I interferon (GO:0034340) | 2.61086178 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 2.59739911 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59011988 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57637622 |
| 54 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56095450 |
| 55 | detection of biotic stimulus (GO:0009595) | 2.54699236 |
| 56 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.53882675 |
| 57 | regulation of early endosome to late endosome transport (GO:2000641) | 2.53219787 |
| 58 | regulation of necroptotic process (GO:0060544) | 2.50967190 |
| 59 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49279018 |
| 60 | regulation of extracellular matrix disassembly (GO:0010715) | 2.48867975 |
| 61 | response to host (GO:0075136) | 2.48827017 |
| 62 | response to host defenses (GO:0052200) | 2.48827017 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48827017 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48526461 |
| 65 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48175930 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48065390 |
| 67 | thymic T cell selection (GO:0045061) | 2.47922390 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.46418099 |
| 69 | positive regulation of extracellular matrix organization (GO:1903055) | 2.46323372 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.46158681 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.45741591 |
| 72 | regulation of tolerance induction (GO:0002643) | 2.44355198 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.44095591 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.43941718 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.41097590 |
| 76 | skin morphogenesis (GO:0043589) | 2.40615737 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.38275489 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 2.36534256 |
| 79 | negative thymic T cell selection (GO:0045060) | 2.36514365 |
| 80 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.36441062 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34376979 |
| 82 | regulation of defense response to virus by virus (GO:0050690) | 2.33745164 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.33068419 |
| 84 | response to host immune response (GO:0052572) | 2.33068419 |
| 85 | tolerance induction (GO:0002507) | 2.28814831 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.28600949 |
| 87 | pentose-phosphate shunt (GO:0006098) | 2.28464121 |
| 88 | cell-substrate adherens junction assembly (GO:0007045) | 2.28382208 |
| 89 | focal adhesion assembly (GO:0048041) | 2.28382208 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27904056 |
| 91 | T cell selection (GO:0045058) | 2.26326763 |
| 92 | cell-substrate junction assembly (GO:0007044) | 2.26185367 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 2.25205470 |
| 94 | negative T cell selection (GO:0043383) | 2.24132441 |
| 95 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.24110877 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.23982270 |
| 97 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23287281 |
| 98 | histone H3-K36 demethylation (GO:0070544) | 2.21682215 |
| 99 | modulation by virus of host process (GO:0019054) | 2.20461870 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.19556345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.54251712 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27738460 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.00707309 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.71866548 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.64416898 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47856781 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44880977 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34818172 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.33659599 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30502749 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22253917 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19801101 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19629077 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19009680 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18779471 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17667396 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.12190433 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09641166 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02130568 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95510179 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92058188 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.91304470 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87259709 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86934735 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85339252 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85123708 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77936541 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77186320 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75069263 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71955018 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70065041 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69365826 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65161648 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63099955 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61152983 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59249357 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58916913 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55824822 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55555977 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53736472 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53141773 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51835471 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50556720 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50483950 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49740926 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49506808 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45247544 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44181838 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42094738 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42009353 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42004444 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38462975 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.37645720 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37280415 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37075847 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35918380 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35253649 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34221670 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32450139 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.31739815 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30385870 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.29271148 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27900764 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.23707855 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22918556 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22783400 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20671573 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19989875 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19985129 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19541076 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18538421 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18106905 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17867346 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16685644 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14973295 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14095922 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13702694 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12786765 |
| 79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11653058 |
| 80 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10298508 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09921070 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09698488 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09340988 |
| 84 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08924660 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08661177 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08660324 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08613269 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07673921 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05038185 |
| 90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04612153 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03970782 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03052510 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02756958 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01229962 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00665618 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97652818 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97652818 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97044493 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96554520 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94080409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.27295970 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.18523222 |
| 3 | MP0003436_decreased_susceptibility_to | 3.17737003 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.02328928 |
| 5 | MP0005451_abnormal_body_composition | 2.81436638 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.53071875 |
| 7 | MP0003724_increased_susceptibility_to | 2.52007132 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.41547502 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.37961162 |
| 10 | MP0008260_abnormal_autophagy | 2.27559735 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.17687089 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.11664872 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.06626977 |
| 14 | MP0002419_abnormal_innate_immunity | 2.02532658 |
| 15 | MP0004947_skin_inflammation | 1.97823063 |
| 16 | MP0000685_abnormal_immune_system | 1.92322048 |
| 17 | MP0000858_altered_metastatic_potential | 1.90985507 |
| 18 | MP0003763_abnormal_thymus_physiology | 1.90759242 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.85931461 |
| 20 | MP0005025_abnormal_response_to | 1.84660281 |
| 21 | MP0009840_abnormal_foam_cell | 1.79126362 |
| 22 | MP0003091_abnormal_cell_migration | 1.78027483 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.77912224 |
| 24 | MP0009785_altered_susceptibility_to | 1.73151829 |
| 25 | MP0001790_abnormal_immune_system | 1.73127602 |
| 26 | MP0005387_immune_system_phenotype | 1.73127602 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.73036139 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.68606002 |
| 29 | MP0006082_CNS_inflammation | 1.65616853 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.62615292 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.62278778 |
| 32 | MP0001800_abnormal_humoral_immune | 1.59961449 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.59953585 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.59758364 |
| 35 | MP0001849_ear_inflammation | 1.58679912 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.53544640 |
| 37 | MP0003828_pulmonary_edema | 1.52327795 |
| 38 | MP0002723_abnormal_immune_serum | 1.50832348 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.49956846 |
| 40 | MP0001819_abnormal_immune_cell | 1.49174885 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.48607294 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.45094550 |
| 43 | MP0002405_respiratory_system_inflammati | 1.39146088 |
| 44 | MP0009278_abnormal_bone_marrow | 1.37626557 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.35756686 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.35146851 |
| 47 | MP0005023_abnormal_wound_healing | 1.35104507 |
| 48 | MP0005671_abnormal_response_to | 1.29384140 |
| 49 | MP0002398_abnormal_bone_marrow | 1.25498866 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.24578359 |
| 51 | MP0003448_altered_tumor_morphology | 1.22863905 |
| 52 | MP0005409_darkened_coat_color | 1.20202420 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.18824618 |
| 54 | MP0000716_abnormal_immune_system | 1.17539527 |
| 55 | MP0001958_emphysema | 1.16924855 |
| 56 | MP0001851_eye_inflammation | 1.16412072 |
| 57 | MP0003075_altered_response_to | 1.16152624 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.16148156 |
| 59 | MP0000604_amyloidosis | 1.15777768 |
| 60 | MP0001915_intracranial_hemorrhage | 1.14008762 |
| 61 | MP0004510_myositis | 1.13224171 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.11605793 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.11309513 |
| 64 | MP0003279_aneurysm | 1.11266149 |
| 65 | MP0004858_abnormal_nervous_system | 1.09762330 |
| 66 | MP0005164_abnormal_response_to | 1.09751733 |
| 67 | MP0001853_heart_inflammation | 1.06308354 |
| 68 | MP0002722_abnormal_immune_system | 1.05886610 |
| 69 | MP0002796_impaired_skin_barrier | 1.05609943 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.05197162 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.04895066 |
| 72 | MP0004381_abnormal_hair_follicle | 1.03841007 |
| 73 | MP0003329_amyloid_beta_deposits | 1.03299899 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.02916114 |
| 75 | MP0000703_abnormal_thymus_morphology | 1.02385341 |
| 76 | MP0002429_abnormal_blood_cell | 1.02258112 |
| 77 | MP0008469_abnormal_protein_level | 1.02247827 |
| 78 | MP0004272_abnormal_basement_membrane | 1.01827174 |
| 79 | MP0000767_abnormal_smooth_muscle | 0.96791728 |
| 80 | MP0004883_abnormal_blood_vessel | 0.96291639 |
| 81 | MP0002132_abnormal_respiratory_system | 0.96105305 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.94480008 |
| 83 | MP0003866_abnormal_defecation | 0.94285467 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.93396524 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.93123723 |
| 86 | MP0002060_abnormal_skin_morphology | 0.91397355 |
| 87 | MP0000343_altered_response_to | 0.90042773 |
| 88 | MP0002933_joint_inflammation | 0.87312377 |
| 89 | MP0000490_abnormal_crypts_of | 0.86590592 |
| 90 | MP0005390_skeleton_phenotype | 0.86524988 |
| 91 | MP0006054_spinal_hemorrhage | 0.86286482 |
| 92 | MP0005621_abnormal_cell_physiology | 0.85106091 |
| 93 | MP0004233_abnormal_muscle_weight | 0.83389985 |
| 94 | MP0005166_decreased_susceptibility_to | 0.82822687 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.82509843 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.82509843 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.82437300 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.82235076 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80518598 |
| 100 | MP0003795_abnormal_bone_structure | 0.79806228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.06812960 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.25708367 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.07913807 |
| 4 | Recurrent abscess formation (HP:0002722) | 2.98026658 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 2.91421077 |
| 6 | Deep venous thrombosis (HP:0002625) | 2.87780352 |
| 7 | Myositis (HP:0100614) | 2.78628424 |
| 8 | Premature rupture of membranes (HP:0001788) | 2.75041100 |
| 9 | Orchitis (HP:0100796) | 2.73070532 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.65906186 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56643882 |
| 12 | Cellulitis (HP:0100658) | 2.44383303 |
| 13 | Peritonitis (HP:0002586) | 2.43844600 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 2.43464745 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.36670601 |
| 16 | Spontaneous hematomas (HP:0007420) | 2.33979719 |
| 17 | Increased IgE level (HP:0003212) | 2.31512815 |
| 18 | Gingivitis (HP:0000230) | 2.29199291 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.28574518 |
| 20 | Optic neuritis (HP:0100653) | 2.28574518 |
| 21 | Arterial tortuosity (HP:0005116) | 2.27882854 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23134198 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23134198 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23134198 |
| 25 | Dilatation of the ascending aorta (HP:0005111) | 2.22804897 |
| 26 | Flat acetabular roof (HP:0003180) | 2.21677580 |
| 27 | Hemorrhage of the eye (HP:0011885) | 2.20640507 |
| 28 | Vascular tortuosity (HP:0004948) | 2.17613672 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.16482200 |
| 30 | Myocardial infarction (HP:0001658) | 2.10221496 |
| 31 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07150523 |
| 32 | Subacute progressive viral hepatitis (HP:0006572) | 2.06289228 |
| 33 | Thin bony cortex (HP:0002753) | 2.04867000 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.04354453 |
| 35 | Asymmetry of the thorax (HP:0001555) | 1.99569702 |
| 36 | Obstructive lung disease (HP:0006536) | 1.99081642 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99081642 |
| 38 | Loss of speech (HP:0002371) | 1.98431591 |
| 39 | Amyloidosis (HP:0011034) | 1.98095028 |
| 40 | Polycythemia (HP:0001901) | 1.97934335 |
| 41 | Increased connective tissue (HP:0009025) | 1.97221574 |
| 42 | Gingival bleeding (HP:0000225) | 1.97088126 |
| 43 | Recurrent viral infections (HP:0004429) | 1.94901607 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 1.94636204 |
| 45 | Polygenic inheritance (HP:0010982) | 1.93814247 |
| 46 | Aneurysm (HP:0002617) | 1.92450097 |
| 47 | Broad face (HP:0000283) | 1.92045642 |
| 48 | Abnormality of the peritoneum (HP:0002585) | 1.92001552 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 1.91609650 |
| 50 | Recurrent fungal infections (HP:0002841) | 1.90307778 |
| 51 | Vasculitis (HP:0002633) | 1.89951799 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89674781 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 1.89674781 |
| 54 | Meningitis (HP:0001287) | 1.87705226 |
| 55 | Mucopolysacchariduria (HP:0008155) | 1.87391140 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87391140 |
| 57 | Recurrent skin infections (HP:0001581) | 1.86455756 |
| 58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85898197 |
| 59 | Spinal cord lesions (HP:0100561) | 1.83815114 |
| 60 | Syringomyelia (HP:0003396) | 1.83815114 |
| 61 | Epistaxis (HP:0000421) | 1.83742828 |
| 62 | Purpura (HP:0000979) | 1.83565669 |
| 63 | Urticaria (HP:0001025) | 1.82238016 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 1.82227797 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 1.82171572 |
| 66 | Arterial thrombosis (HP:0004420) | 1.82144364 |
| 67 | Slow saccadic eye movements (HP:0000514) | 1.81473936 |
| 68 | Abnormality of oral frenula (HP:0000190) | 1.81307486 |
| 69 | Cervical subluxation (HP:0003308) | 1.81148073 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81035727 |
| 71 | Colitis (HP:0002583) | 1.80740826 |
| 72 | Spondylolisthesis (HP:0003302) | 1.80566318 |
| 73 | Ankyloglossia (HP:0010296) | 1.80246991 |
| 74 | Pustule (HP:0200039) | 1.79557999 |
| 75 | Increased variability in muscle fiber diameter (HP:0003557) | 1.79257750 |
| 76 | Aortic aneurysm (HP:0004942) | 1.78418151 |
| 77 | Blue sclerae (HP:0000592) | 1.77983588 |
| 78 | Aortic dissection (HP:0002647) | 1.77095332 |
| 79 | Cerebral inclusion bodies (HP:0100314) | 1.75931166 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 1.75079487 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75013863 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75013863 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75013863 |
| 84 | Hyperacusis (HP:0010780) | 1.74953146 |
| 85 | Disproportionate tall stature (HP:0001519) | 1.73766093 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.72252212 |
| 87 | Abnormality of complement system (HP:0005339) | 1.72155012 |
| 88 | T lymphocytopenia (HP:0005403) | 1.71899924 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71589286 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.70487570 |
| 91 | Inflammation of the large intestine (HP:0002037) | 1.70073846 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 1.69584668 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.69426309 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 1.68456219 |
| 95 | Prolonged bleeding time (HP:0003010) | 1.68041180 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.65342781 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.65060744 |
| 98 | Emphysema (HP:0002097) | 1.64646647 |
| 99 | Osteomyelitis (HP:0002754) | 1.63510868 |
| 100 | Bone pain (HP:0002653) | 1.63227102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.66810351 |
| 2 | TRIB3 | 3.61002531 |
| 3 | ERN1 | 3.05353614 |
| 4 | RIPK4 | 2.51985468 |
| 5 | SMG1 | 2.47888591 |
| 6 | FGFR4 | 2.46867923 |
| 7 | IRAK3 | 2.17462406 |
| 8 | MAP4K1 | 2.09863067 |
| 9 | MAP2K3 | 2.09727282 |
| 10 | TYK2 | 2.02847992 |
| 11 | ICK | 1.98463197 |
| 12 | RIPK1 | 1.96353304 |
| 13 | CDK12 | 1.96031576 |
| 14 | MAP3K13 | 1.94116456 |
| 15 | MAP3K14 | 1.86042866 |
| 16 | SIK1 | 1.81953233 |
| 17 | MAP3K3 | 1.74196176 |
| 18 | EPHB1 | 1.71809913 |
| 19 | ZAP70 | 1.65014180 |
| 20 | KSR2 | 1.58592968 |
| 21 | CSK | 1.57335758 |
| 22 | IRAK4 | 1.54900020 |
| 23 | PDGFRA | 1.52756892 |
| 24 | EEF2K | 1.45678434 |
| 25 | TTN | 1.40332969 |
| 26 | TAOK2 | 1.37100252 |
| 27 | JAK3 | 1.34710041 |
| 28 | FGFR3 | 1.33813145 |
| 29 | PKN2 | 1.33517704 |
| 30 | MAP3K1 | 1.26365929 |
| 31 | PAK4 | 1.23401180 |
| 32 | BLK | 1.22600901 |
| 33 | TBK1 | 1.22107800 |
| 34 | JAK1 | 1.21573338 |
| 35 | MAP3K10 | 1.18446708 |
| 36 | PTK6 | 1.12950106 |
| 37 | SIK3 | 1.12570979 |
| 38 | CDC42BPA | 1.09721927 |
| 39 | GRK6 | 1.07063010 |
| 40 | TAOK1 | 1.06275238 |
| 41 | FGR | 1.03588134 |
| 42 | FES | 0.98096396 |
| 43 | TGFBR2 | 0.97525732 |
| 44 | PDPK1 | 0.93550555 |
| 45 | CDK6 | 0.90242831 |
| 46 | MARK2 | 0.89490193 |
| 47 | HCK | 0.88430947 |
| 48 | BTK | 0.86359064 |
| 49 | MAP3K11 | 0.86114754 |
| 50 | EPHA2 | 0.86085051 |
| 51 | MAP3K2 | 0.84200432 |
| 52 | LRRK2 | 0.83950836 |
| 53 | IKBKE | 0.81676979 |
| 54 | TESK2 | 0.80657181 |
| 55 | RET | 0.79957889 |
| 56 | LATS2 | 0.79197300 |
| 57 | JAK2 | 0.78950996 |
| 58 | STK10 | 0.77561005 |
| 59 | PRKD2 | 0.76976106 |
| 60 | MAP3K6 | 0.75666476 |
| 61 | NEK9 | 0.74100282 |
| 62 | YES1 | 0.73083047 |
| 63 | NME2 | 0.71858572 |
| 64 | MAP3K8 | 0.71397218 |
| 65 | PDK1 | 0.70969149 |
| 66 | ARAF | 0.70450538 |
| 67 | MOS | 0.68441077 |
| 68 | SCYL2 | 0.66946238 |
| 69 | TESK1 | 0.65677239 |
| 70 | CSF1R | 0.65624701 |
| 71 | IRAK2 | 0.64821443 |
| 72 | PDGFRB | 0.61583224 |
| 73 | CDK4 | 0.61185791 |
| 74 | MTOR | 0.60213115 |
| 75 | MAPK11 | 0.60149144 |
| 76 | TYRO3 | 0.59889789 |
| 77 | LCK | 0.58326071 |
| 78 | PTK2 | 0.56383428 |
| 79 | STK38 | 0.56057525 |
| 80 | RPS6KA2 | 0.55052315 |
| 81 | HIPK2 | 0.54659879 |
| 82 | BMX | 0.54177196 |
| 83 | SIK2 | 0.53090676 |
| 84 | SGK3 | 0.51344599 |
| 85 | SYK | 0.51115222 |
| 86 | RPS6KL1 | 0.50997451 |
| 87 | RPS6KC1 | 0.50997451 |
| 88 | ITK | 0.47489052 |
| 89 | DDR2 | 0.46789348 |
| 90 | MAP3K7 | 0.46526640 |
| 91 | MAP3K9 | 0.46081318 |
| 92 | MST1R | 0.45384712 |
| 93 | LYN | 0.45167202 |
| 94 | MATK | 0.44262846 |
| 95 | PRKG2 | 0.43879246 |
| 96 | CLK1 | 0.42926191 |
| 97 | MELK | 0.42278155 |
| 98 | MARK3 | 0.42257706 |
| 99 | MAPK12 | 0.41707006 |
| 100 | KSR1 | 0.40672538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64718358 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.24378644 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12300722 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.00623636 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93726469 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89551156 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.85547208 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69924857 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68673378 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68014584 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.60996137 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53436278 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53373618 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49820166 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.44862530 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42662037 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40860525 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40693069 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40495494 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.39791099 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38079771 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35799516 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35471623 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.34878822 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.34101772 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34055805 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.33751225 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.31176745 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30169121 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.27079114 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25874233 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.24027341 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23446793 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22267391 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21208834 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.17946657 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.16728685 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14731155 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.14680943 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.14295123 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.12309684 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07445397 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06754294 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05875790 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05525762 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.05019200 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.03475870 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01526398 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.01514253 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00431438 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00058685 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99352912 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98348654 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98098966 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.97327467 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.95649144 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92873045 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91465357 |
| 59 | Prostate cancer_Homo sapiens_hsa05215 | 0.91361116 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90846340 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90833290 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.89006593 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.88545786 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.86407797 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.85140264 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84588771 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83270833 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83048121 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82595581 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82324040 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82254312 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.81904041 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81839888 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80041427 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79393475 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78092358 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.77906116 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77366293 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77322976 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76580298 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75265742 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73993159 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73482382 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73332843 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73178177 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.73010038 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71085930 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69997994 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69781072 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69420025 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68583171 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68320648 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65466907 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65197905 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63667715 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63452634 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61658721 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54686684 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52115284 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51520884 |

